Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "CHEST"

Add to list
- Journal Article
- A1
- open access
Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap

Catherine John, Anna L. Guyatt, Nick Shrine, Richard Packer, Thorunn A. Olafsdottir, Jiangyuan Liu, Lystra P. Hayden, Su H. Chu, Jukka T. Koskela, Jian’an Luan, et al.

(2022) CHEST. 161(5). p.1155-1166
Add to list
- Journal Article
- A1
- open access
Safety and outcomes of amikacin liposome inhalation suspension for Mycobacterium abscessus pulmonary disease : a NTM-NET

Sanne Maria Henriette Zweijpfenning, Raphael Chiron, Sharon Essink, Jodie Schildkraut, Onno W. Akkerman, Stefano Aliberti, Josje Altenburg, Bert Arets, Eva Van Braeckel (UGent) , Bénédicte Delaere, et al.

(2022) CHEST. 162(1). p.76-81
Add to list
- Miscellaneous
Benefits of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers on progression of emphysema and lung function decline

Xander Bertels (UGent) and Lies Lahousse (UGent)

(2021) CHEST. 160(4). p.1160-1162
Add to list
- Journal Article
- A1
- open access
Eosinophilic and noneosinophilic asthma : an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort

Liam G. Heaney, Luis Perez de Llano, Mona Al-Ahmad, Vibeke Backer, John Busby, Giorgio Walter Canonica, George C. Christoff, Borja G. Cosio, J. Mark FitzGerald, Enrico Heffler, et al.

(2021) CHEST. 160(3). p.814-830
Add to list
Aspiration risk factors, microbiology, and empiric antibiotics for patients hospitalized with community-acquired pneumonia

Judith Marin-Corral, Sergi Pascual-Guardia, Francesco Amati, Stefano Aliberti, Joan R. Masclans, Nilam Soni, Alejandro Rodriguez, Oriol Sibila, Francisco Sanz, Giovanni Sotgiu, et al.

(2021) CHEST. 159(1). p.58-72
Add to list
- Miscellaneous
Personalizing oral corticosteroid dose in severe COPD exacerbations

Lies Lahousse (UGent)

(2021) CHEST. 160(5). p.1581-1582
Add to list
- Journal Article
- A1
- open access
Objectively measured physical activity as a COPD clinical trial outcome

Chris Burtin, Divya Mohan, Thierry Troosters, Henrik Watz, Nicholas S. Hopkinson, Judith Garcia-Aymerich, Marilyn L. Moy, Ioannis Vogiatzis, Harry B. Rossiter, Sally Singh, et al.

(2021) CHEST. 160(6). p.2080-2100
Add to list
- Conference Paper
- C3
Association between asthma severity, quality of life, and productivity in France, Germany, Italy, Spain, and the United Kingdom

Asif H. Khan (UGent) , Nikoletta Sternbach, Siddhesh Kamat, Kathy Annunziata, Dena Jaffe and Imène Gouia

(2020) CHEST. In Chest 158(4). p.47A-47A
Add to list
- Conference Paper
- C3
Dupilumab reduces severe outpatient asthma exacerbations, cumulative dose, and total number of days of systemic corticosteroid use among patients with moderate-to-severe type-2 asthma

Giorgio Walter Canonica, Robert Zeiger, Mario Castro, Jerome Msihid, Benjamin Ortiz, Nami Pandit-Abid, Siddhesh Kamat and Asif H. Khan (UGent)

(2020) CHEST. In Chest 158(4). p.A1810-A1812
Add to list
- Conference Paper
- C3
Prevalence of asthma in France, Germany, Italy, Spain, and the United Kingdom, based on the 2018 European National Health and Wellness survey

Asif H. Khan (UGent) , Nikoletta Sternbach, Siddhesh Kamat, Kathy Annunziata, Dena Jaffe and Imène Gouia

(2020) CHEST. In Chest 158(4). p.27A-27A

Academic Bibliography

Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap

Safety and outcomes of amikacin liposome inhalation suspension for Mycobacterium abscessus pulmonary disease : a NTM-NET

Benefits of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers on progression of emphysema and lung function decline

Eosinophilic and noneosinophilic asthma : an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort

Aspiration risk factors, microbiology, and empiric antibiotics for patients hospitalized with community-acquired pneumonia

Personalizing oral corticosteroid dose in severe COPD exacerbations

Objectively measured physical activity as a COPD clinical trial outcome

Association between asthma severity, quality of life, and productivity in France, Germany, Italy, Spain, and the United Kingdom

Dupilumab reduces severe outpatient asthma exacerbations, cumulative dose, and total number of days of systemic corticosteroid use among patients with moderate-to-severe type-2 asthma

Prevalence of asthma in France, Germany, Italy, Spain, and the United Kingdom, based on the 2018 European National Health and Wellness survey

Contents

Support

Contact